Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
24.91
+0.13 (0.52%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Elanco Animal Health Employees
As of December 31, 2025, Elanco Animal Health had 9,900 total employees, including 9,400 full-time and 500 part-time employees. The number of employees increased by 450 or 4.76% compared to the previous year.
Employees
9,900
Change (1Y)
450
Growth (1Y)
4.76%
Revenue / Employee
$494,242
Profits / Employee
-$24,444
Market Cap
12.44B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9,900 | 450 | 4.76% | 9,400 | 500 |
| Dec 31, 2024 | 9,450 | -350 | -3.57% | 9,000 | 450 |
| Dec 31, 2023 | 9,800 | 60 | 0.62% | 9,300 | 500 |
| Dec 31, 2022 | 9,740 | 740 | 8.22% | 9,000 | 740 |
| Dec 31, 2021 | 9,000 | -1,200 | -11.76% | 9,000 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Zoetis | 14,500 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| United Therapeutics | 1,400 |
ELAN News
- 3 days ago - Elanco price target raised to $26 from $23 at Morgan Stanley - TheFly
- 3 days ago - Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets) - PRNewsWire
- 17 days ago - Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement - PRNewsWire
- 5 weeks ago - Elanco price target raised to $32 from $31 at TD Cowen - TheFly
- 5 weeks ago - Elanco to launch Elanco Ventures for animal health innovation - TheFly
- 5 weeks ago - Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health - PRNewsWire
- 5 weeks ago - Elanco announces USDA approval of TruCan Ultra Lyme-L4 - TheFly
- 5 weeks ago - Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs - PRNewsWire